Author:
Olschewski Daniel Navin,Nazarzadeh Nilufar,Lange Felix,Koenig Anna Maria,Kulka Christina,Abraham Jella-Andrea,Blaschke Stefan Johannes,Merkel Rudolf,Hoffmann Bernd,Fink Gereon Rudolf,Schroeter Michael,Rueger Maria Adele,Vay Sabine Ulrike
Abstract
Abstract
Background
Astrocytes are the most abundant cell type of the central nervous system and are fundamentally involved in homeostasis, neuroprotection, and synaptic plasticity. This regulatory function of astrocytes on their neighboring cells in the healthy brain is subject of current research. In the ischemic brain we assume disease specific differences in astrocytic acting. The renin–angiotensin–aldosterone system regulates arterial blood pressure through endothelial cells and perivascular musculature. Moreover, astrocytes express angiotensin II type 1 and 2 receptors. However, their role in astrocytic function has not yet been fully elucidated. We hypothesized that the angiotensin II receptors impact astrocyte function as revealed in an in vitro system mimicking cerebral ischemia.
Astrocytes derived from neonatal wistar rats were exposed to telmisartan (angiotensin II type 1 receptor-blocker) or PD123319 (angiotensin II type 2 receptor-blocker) under normal conditions (control) or deprivation from oxygen and glucose. Conditioned medium (CM) of astrocytes was harvested to elucidate astrocyte-mediated indirect effects on microglia and cortical neurons.
Result
The blockade of angiotensin II type 1 receptor by telmisartan increased the survival of astrocytes during ischemic conditions in vitro without affecting their proliferation rate or disturbing their expression of S100A10, a marker of activation. The inhibition of the angiotensin II type 2 receptor pathway by PD123319 resulted in both increased expression of S100A10 and proliferation rate. The CM of telmisartan-treated astrocytes reduced the expression of pro-inflammatory mediators with simultaneous increase of anti-inflammatory markers in microglia. Increased neuronal activity was observed after treatment of neurons with CM of telmisartan- as well as PD123319-stimulated astrocytes.
Conclusion
Data show that angiotensin II receptors have functional relevance for astrocytes that differs in healthy and ischemic conditions and effects surrounding microglia and neuronal activity via secretory signals. Above that, this work emphasizes the strong interference of the different cells in the CNS and that targeting astrocytes might serve as a therapeutic strategy to influence the acting of glia-neuronal network in de- and regenerative context.
Funder
Gerok Program
Köln Fortune Program
Cologne Clinician Scientist Program
Deutsche Forschungsgemeinschaft
Marga und Walter Boll-Stiftung
Universitätsklinikum Köln
Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Kim JH, Afridi R, Cho E, Yoon JH, Lim YH, Lee HW, et al. Soluble ANPEP released from human astrocytes as a positive regulator of microglial activation and neuroinflammation: brain renin–angiotensin system in astrocyte-microglia crosstalk. Mol Cell Proteomics. 2022;21: 100424.
2. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32:638.
3. Vay SU, Olschewski DN, Petereit H, Lange F, Nazarzadeh N, Gross E, et al. Osteopontin regulates proliferation, migration, and survival of astrocytes depending on their activation phenotype. J Neurosci Res. 2021;99:2822–43.
4. Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;2021:1–6.
5. Liddelow SA, Barres BA. Reactive astrocytes: production, function, and therapeutic potential. Immunity. 2017;46:957–67.